Device Sublime Microcatheter, 035, 200cm, Angle

Sublime Microcatheter, 035, 200cm, Angle

Payments companies reported to CMS as associated with Sublime Microcatheter, 035, 200cm, Angle. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$14Kassociated payments (2023-2025)
48clinicians with associated payments
1company reporting

By year

2024 $14K

Payments reported as associated with Sublime Microcatheter, 035, 200cm, Angle, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Interventional Cardiology $13K
Vascular Surgery $416
Rheumatology $116
Cardiovascular Disease $111
Internal Medicine $93.47
Acute Care (Nurse Practitioner) $82.44

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Sublime Microcatheter, 035, 200cm, Angle

These are the largest totals companies reported as associated with Sublime Microcatheter, 035, 200cm, Angle. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Pradeep Nair Houma, LA Interventional Cardiology $6,662.87
Ankur Lodha Lafayette, LA Interventional Cardiology $4,122.71
Anish Thomas Saint Louis, MO Interventional Cardiology $750.00
Amit Srivastava Edgewood, KY Interventional Cardiology $622.97
Sameh Sayfo Plano, TX Interventional Cardiology $434.64
Luis Leon Phoenix, AZ Vascular Surgery $153.90
Mohammad Alqaim Fort Worth, TX Vascular Surgery $153.90
Matthew Finn Houma, LA Interventional Cardiology $150.31
Charles Thompson Zachary, LA Interventional Cardiology $121.77
Venkata Gadi Baton Rouge, LA Interventional Cardiology $116.15

Prescribed Sublime Microcatheter, 035, 200cm, Angle?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.